SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-034447
Filing Date
2015-04-15
Accepted
2015-04-15 21:16:55
Documents
1
Period of Report
2015-04-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1561
  Complete submission text file 0001209191-15-034447.txt   3002
Mailing Address 2656 CROSSPARK ROAD, SUITE 100 CORALVILLE IA 52241
Business Address 2656 CROSSPARK ROAD, SUITE 100 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Issuer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O THE LGL GROUP, INC. 2525 SHADER ROAD ORLANDO FL 32804
Business Address
Clifton R. LaDuane (Reporting) CIK: 0001488774 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36913 | Film No.: 15773057